• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从天然药物、分子靶点和症状群的角度探索骨质疏松症的分类与治疗。

Exploring the classification and treatment of osteoporosis from the perspectives of natural medicines, molecular targets, and symptom clusters.

作者信息

Zhang Yili, Guo Xiangyun, Sun Kai, Wang Liang, Huang Siyuan, Gan Yiwen, Qin Jinran, Liu Qingqing, Li Yan, Jin Zikai, Zhu Liguo, Wei Xu

机构信息

School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, Jiangsu, China.

Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, China.

出版信息

Sci Rep. 2025 Mar 25;15(1):10218. doi: 10.1038/s41598-025-95304-3.

DOI:10.1038/s41598-025-95304-3
PMID:40133588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11937308/
Abstract

Osteoporosis (OP) is a metabolic bone disease characterized by reduced bone density and fragility, impairing quality of life. Traditional treatments often overlook symptoms like back and joint pain, increasing burden. This study aims to map relationships between natural medicines, targets, and symptom clusters, demonstrating their effectiveness in personalized OP treatment to enhance clinical strategies and self-assessment. We used compounds and targets, applying Summary data-based Mendelian Randomisation (SMR) analysis for biological process and molecular function enrichment. Additionally, we employed Phenome-Wide Association Studies (PheWAS) to select two natural drugs-Rhizoma Drynariae (RD) and Lycii Fructus (LF)-for case analysis. The study found that RD primarily improves symptoms such as indigestion, constipation, fatigue, polyuria, and depression, while LF significantly ameliorates symptoms related to the nervous and muscular systems, such as hoarseness, dizziness, vertigo, and fever symptoms. This analysis successfully differentiated two groups of symptoms and precisely constructed a logical chain among "natural Medicines-molecular tArGets-Illness-symptom Clusters" (MAGIC chain) achieving a refined classification of OP. The results of this study support the effectiveness of implementing personalized medical strategies in the treatment of OP, providing a scientific basis for the clinical application of natural medicines and patient self-management.

摘要

骨质疏松症(OP)是一种代谢性骨病,其特征是骨密度降低和骨脆性增加,会损害生活质量。传统治疗方法往往忽视背部和关节疼痛等症状,从而增加了负担。本研究旨在梳理天然药物、靶点和症状群之间的关系,证明它们在骨质疏松症个性化治疗中的有效性,以加强临床策略和自我评估。我们使用化合物和靶点,应用基于汇总数据的孟德尔随机化(SMR)分析进行生物过程和分子功能富集。此外,我们采用全表型关联研究(PheWAS)选择两种天然药物——骨碎补(RD)和枸杞子(LF)进行病例分析。研究发现,骨碎补主要改善消化不良、便秘、疲劳、多尿和抑郁等症状,而枸杞子则显著改善与神经和肌肉系统相关的症状,如声音嘶哑、头晕、眩晕和发热症状。该分析成功区分了两组症状,并精确构建了“天然药物-分子靶点-疾病-症状群”(MAGIC链)之间的逻辑链,实现了骨质疏松症的精细化分类。本研究结果支持在骨质疏松症治疗中实施个性化医疗策略的有效性,为天然药物的临床应用和患者自我管理提供了科学依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/019c0ff0b67e/41598_2025_95304_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/ae4c9233908a/41598_2025_95304_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/af84fecccf21/41598_2025_95304_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/884a47716137/41598_2025_95304_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/9e16484d717c/41598_2025_95304_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/2f7b55b4cf52/41598_2025_95304_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/019c0ff0b67e/41598_2025_95304_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/ae4c9233908a/41598_2025_95304_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/af84fecccf21/41598_2025_95304_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/884a47716137/41598_2025_95304_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/9e16484d717c/41598_2025_95304_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/2f7b55b4cf52/41598_2025_95304_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f064/11937308/019c0ff0b67e/41598_2025_95304_Fig6_HTML.jpg

相似文献

1
Exploring the classification and treatment of osteoporosis from the perspectives of natural medicines, molecular targets, and symptom clusters.从天然药物、分子靶点和症状群的角度探索骨质疏松症的分类与治疗。
Sci Rep. 2025 Mar 25;15(1):10218. doi: 10.1038/s41598-025-95304-3.
2
[Review for treatment effect and signaling pathway regulation of kidney-tonifying traditional Chinese medicine on osteoporosis].[补肾中药对骨质疏松症的治疗作用及信号通路调控研究综述]
Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(1):21-30. doi: 10.19540/j.cnki.cjcmm.20171106.002.
3
Network Pharmacology-Based Pharmacological Mechanism of the Chinese Medicine Rhizoma drynariae Against Osteoporosis.基于网络药理学的中药骨碎补治疗骨质疏松症的药理机制。
Med Sci Monit. 2019 Aug 1;25:5700-5716. doi: 10.12659/MSM.915170.
4
UPLC-MS metabolomics method provides valuable insights into the effect and underlying mechanisms of Rhizoma Drynariae protecting osteoporosis.UPLC-MS 代谢组学方法为研究密花豆保护骨质疏松症的作用及潜在机制提供了有价值的见解。
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Sep 1;1152:122262. doi: 10.1016/j.jchromb.2020.122262. Epub 2020 Jul 11.
5
Exploring the mechanism of action Xianlingubao Prescription in the treatment of osteoporosis by network pharmacology.网络药理学探讨仙灵骨葆方治疗骨质疏松症的作用机制。
Comput Biol Chem. 2020 Apr;85:107240. doi: 10.1016/j.compbiolchem.2020.107240. Epub 2020 Feb 26.
6
[Summary and Analysis of the Application of Natural Medicine in the Treatment of Osteoporosis].[天然药物在骨质疏松症治疗中的应用总结与分析]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 20;55(6):1610-1614. doi: 10.12182/20241160511.
7
Kidney tissue targeted metabolic profiling of glucocorticoid-induced osteoporosis and the proposed therapeutic effects of Rhizoma Drynariae studied using UHPLC/MS/MS.使用超高效液相色谱/串联质谱法研究糖皮质激素诱导的骨质疏松症的肾组织靶向代谢谱以及骨碎补的潜在治疗作用。
Biomed Chromatogr. 2014 Jun;28(6):878-84. doi: 10.1002/bmc.3194.
8
Network pharmacology identifies fisetin as a treatment for osteoporosis that activates the Wnt/β-catenin signaling pathway in BMSCs.网络药理学鉴定非瑟酮可通过激活 BMSCs 中的 Wnt/β-catenin 信号通路治疗骨质疏松症。
J Orthop Surg Res. 2023 Apr 22;18(1):312. doi: 10.1186/s13018-023-03761-1.
9
Assessing the causal relationship between plasma proteins and osteoporosis: novel insights into pathological mechanisms and therapeutic implications.评估血浆蛋白与骨质疏松症之间的因果关系:对病理机制和治疗意义的新认识。
Osteoporos Int. 2024 Nov;35(11):1973-1987. doi: 10.1007/s00198-024-07225-y. Epub 2024 Aug 9.
10
Insight of Chinese Herbal Medicine in Treating Osteoporosis: Achievements from 2013 to 2023.中药治疗骨质疏松症的研究进展:2013年至2023年的成果
Am J Chin Med. 2024;52(5):1303-1328. doi: 10.1142/S0192415X24500526. Epub 2024 Aug 28.

本文引用的文献

1
Senescent Macrophages and the Lung Cancer Microenvironment: A New Perspective on Tumor Immune Evasion.衰老巨噬细胞与肺癌微环境:肿瘤免疫逃逸的新视角
Aging Dis. 2024 Dec 31. doi: 10.14336/AD.2024.1404.
2
The Critical Role of Trace Elements in Bone Health.微量元素在骨骼健康中的关键作用。
Nutrients. 2024 Nov 13;16(22):3867. doi: 10.3390/nu16223867.
3
KEGG: biological systems database as a model of the real world.京都基因与基因组百科全书(KEGG):作为现实世界模型的生物系统数据库。
Nucleic Acids Res. 2025 Jan 6;53(D1):D672-D677. doi: 10.1093/nar/gkae909.
4
Rhizoma Drynariae-derived nanovesicles reverse osteoporosis by potentiating osteogenic differentiation of human bone marrow mesenchymal stem cells targeting ER signaling.骨碎补来源的纳米囊泡通过增强靶向雌激素受体信号通路的人骨髓间充质干细胞成骨分化来逆转骨质疏松症
Acta Pharm Sin B. 2024 May;14(5):2210-2227. doi: 10.1016/j.apsb.2024.02.005. Epub 2024 Feb 10.
5
[Expert consensus on integrated traditional Chinese and western medicine diagnosis and treatment for osteoporotic fractures].《骨质疏松性骨折中西医结合诊疗专家共识》
Zhongguo Gu Shang. 2024 Mar 25;37(3):242-50. doi: 10.12200/j.issn.1003-0034.20240002.
6
Expert consensus on Prospective Precision Diagnosis and Treatment Strategies for Osteoporotic Fractures.骨质疏松性骨折前瞻性精准诊断与治疗策略专家共识
Aging Dis. 2024 Feb 29;16(1):67-76. doi: 10.14336/AD.2023.1223.
7
Network pharmacology-based pharmacological mechanism prediction of Lycii Fructus against postmenopausal osteoporosis.基于网络药理学的枸杞子防治绝经后骨质疏松症的药理机制预测。
Medicine (Baltimore). 2023 Dec 1;102(48):e36292. doi: 10.1097/MD.0000000000036292.
8
LBP1C-2 from Lycium barbarum alleviated age-related bone loss by targeting BMPRIA/BMPRII/Noggin.宁夏枸杞 LBP1C-2 通过靶向 BMPRIA/BMPRII/Noggin 缓解与年龄相关的骨丢失。
Carbohydr Polym. 2023 Jun 15;310:120725. doi: 10.1016/j.carbpol.2023.120725. Epub 2023 Feb 23.
9
FinnGen provides genetic insights from a well-phenotyped isolated population.FinnGen 为一个表型良好的隔离人群提供了遗传学方面的见解。
Nature. 2023 Jan;613(7944):508-518. doi: 10.1038/s41586-022-05473-8. Epub 2023 Jan 18.
10
Cell death regulation: A new way for natural products to treat osteoporosis.细胞死亡调控:天然产物治疗骨质疏松症的新途径。
Pharmacol Res. 2023 Jan;187:106635. doi: 10.1016/j.phrs.2022.106635. Epub 2022 Dec 26.